Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Clinical Trial Data: Share and Share Alike?

Clinical Trial Data: Share and Share Alike? News & Analysis Medical News & Perspectives .......p881 Lab Reports....................................p885 News From the CDC.......................p886 Clinical Trial Data: Share and Share Alike? Cooler Temps Diminish Immune Response Rebuilding Haiti’s Health System Against Rhinovirus in Mice Alcohol Poisoning Deaths The JAMA Forum ...........................p883 Soil Screening Research Uncovers Hit Middle-Aged Men Hardest Leading by Example—Health Systems Improving Promising New Antibiotic the Care of Employees Oxytocin Restores Sociability in a Mouse Model of Autism Analysis Provides Map of Protein Expression in Human Tissues Medical News & Perspectives Mike Mitka, MSJ key question for investigators con- whether they are subject to FDA registra- ductingclinicaltrialshaschangeddi- tion and results submission requirements. A rection. Instead of asking why they In addition, the European Federation should share data with other researchers or of Pharmaceutical Industries and Associa- drug and medical device manufacturers, tions and the Pharmaceutical Research they’re more likely to ask how to dissemi- and Manufacturers of America imple- nate the information. mented their own principles for respon- Reluctance to share data has been the sible clinical trial data sharing in January norm rather than the exception, leading to 2014. During the same month, Johnson & fewer published clinical trial results and a Johnson agreed to partner http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Clinical Trial Data: Share and Share Alike?

Mitka, Mike
JAMA , Volume 313 (9) – Mar 3, 2015
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/clinical-trial-data-share-and-share-alike-VV4nQwevT7

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2015.481
pmid
25734721
Publisher site
See Article on Publisher Site

Abstract

News & Analysis Medical News & Perspectives .......p881 Lab Reports....................................p885 News From the CDC.......................p886 Clinical Trial Data: Share and Share Alike? Cooler Temps Diminish Immune Response Rebuilding Haiti’s Health System Against Rhinovirus in Mice Alcohol Poisoning Deaths The JAMA Forum ...........................p883 Soil Screening Research Uncovers Hit Middle-Aged Men Hardest Leading by Example—Health Systems Improving Promising New Antibiotic the Care of Employees Oxytocin Restores Sociability in a Mouse Model of Autism Analysis Provides Map of Protein Expression in Human Tissues Medical News & Perspectives Mike Mitka, MSJ key question for investigators con- whether they are subject to FDA registra- ductingclinicaltrialshaschangeddi- tion and results submission requirements. A rection. Instead of asking why they In addition, the European Federation should share data with other researchers or of Pharmaceutical Industries and Associa- drug and medical device manufacturers, tions and the Pharmaceutical Research they’re more likely to ask how to dissemi- and Manufacturers of America imple- nate the information. mented their own principles for respon- Reluctance to share data has been the sible clinical trial data sharing in January norm rather than the exception, leading to 2014. During the same month, Johnson & fewer published clinical trial results and a Johnson agreed to partner

Journal

JAMA – American Medical Association

Published: Mar 3, 2015

There are no references for this article.